The anthelmintic drug, levamisole, causes hypercontraction of body-wall muscles and lethality in nematode worms. In the nematode Caenorhabditis elegans, a genetic screen for levamisole resistance has identified 11 genes, 3 of which (unc-38, unc-29 and lev-1) encode nicotinic acetylcholine receptor (nAChR) subunits. Here we describe the molecular and functional characterization of another levamisole-resistance gene, unc-63, encoding a nAChR α subunit with a predicted amino acid sequence most similar to that of UNC-38. Like UNC-38 and UNC-29, UNC-63 is expressed in body wall muscles. In addition, UNC-63 is expressed in vulval muscles and neurons. We also show that the LEV-1 is expressed in body wall muscle, thus overlapping the cellular localization of UNC-63, UNC-38 and UNC-29 and suggesting possible association in vivo. This is supported by electrophysiological studies on body wall muscle, which demonstrate that a levamisole-sensitive nAChR present at the C. elegans neuromuscular junction requires both UNC-63 and LEV-1 subunits. Thus, at least four subunits, two α types (UNC-38 and UNC-63) and two non-α types (UNC-29 and LEV-1), can contribute to levamisole-sensitive muscle nAChRs in nematodes. 
INTRODUCTION
Nicotinic acetylcholine receptors (nAChRs) are Cys-loop ligand-gated ion channels (LGICs) formed by 5 polypeptide subunits (1) . Typical features of Cys-loop LGICs include an N-terminal extracellular domain where ligand binding occurs, the Cys-loop which is two disulphide-bonded cysteines separated by 13 residues and four transmembrane regions (M1-4), the second of which contains many channel lining residues (2) . The nAChR subunits possessing two adjacent cysteines in the acetylcholine (ACh) binding site are referred to as α subunits whereas those with no such motif are referred to as non-α subunits (β, γ, δ and ε). Birds and mammals possess 17 subunits characterized as either 'muscle' (α1, β1, γ, δ and ε) or 'neuronal' (α2-10, β2-4) subtypes (3, 4) . Recent analysis of the pufferfish genome has revealed a larger nAChR gene family consisting of 28 subunits that probably arose through genome duplication (5) . One of the most extensive and diverse nAChR gene families currently known is that of the nematode Caenorhabditis elegans which consists of at least 27 subunits (6).
Early investigations of C. elegans mutants identified 11 loci that mediate resistance to the anthelmintic drug, levamisole, which causes paralysis of nematode body wall muscles (7) (8) (9) .
Among the 11 levamisole-resistant loci, it has been shown that lev-1 and unc-29 both encode non-α nAChR subunits, whereas unc-38 encodes a nAChR α subunit (10) . Expression in Xenopus laevis oocytes of combinations of these subunits that include UNC-38 resulted in small amplitude, dose-dependent, inward currents in response to ACh and levamisole that were suppressed by several nAChR antagonists (10) Four other genes mediating levamisole resistance have been identified. These are: unc-22, the product of which is known as twitchin (12) ; unc-50 which encodes for a novel transmembrane protein (13) ; unc-68 which encodes for a ryanodine receptor (14) ; lev-11 which encodes for tropomyosin (15) . The characterization of the remaining levamisole resistance loci (unc-63, unc-74, lev-9 and lev-10) have yet to be reported. Here we describe the cloning of a new nAChR α subunit and show that it corresponds to the unc-63 locus (7, 8) . GFP reporter constructs reveal that UNC-63 is expressed in body wall muscles as well as neurons. Using electrophysiology on muscle preparations, we also show that unc-63 is necessary for the function of the levamisole-sensitive nAChR at the neuromuscular junction. Tests for levamisole sensitivity and locomotor function. The sensitivity to levamisole was assessed on NGM plates containing 1 mM levamisole. Locomotion was assessed by transferring adult hermaphrodites to NGM (nematode growth media) plates without levamisole and after 1 hour counting the number of body bends per minute.
DNA extraction and sequencing. Cloning was carried out using standard methods (17). The C. elegans genomic DNA extraction protocol was obtained from http://www.dartmouth.edu/artsci/bio/ambros/protocols/worm_protocols.html. Plasmid DNA for micro-injection into nematodes was purified using a Qiagen plasmid mini kit (Qiagen, UK).
Sequencing was performed at the Babraham Institute or at the Oxford University Biochemistry Department Sequencing Facility.
Cloning jtf#38 cDNA. A mixed-stage N2 cDNA library in λgt10 (provided by S. Kim) was hybridized with an unc-38 probe at 50°C as previously described (10) . The final washes were carried out at moderate stringency (65°C in 2xSSC, 0.1 % SDS). Sequence analysis revealed that one of the positive clones, jtf#38, contained a partial cDNA homologous to nAChR subunits. The 5' and 3' ends of the jtf#38 coding region was determined using the 5'/3' RACE kit (Roche).
Sequence analysis. Sequence alignment and analysis were performed using the GCG packaging, CLUSTALW. The BLAST alignment tool (18) was used to search the genome database.
Genetic localization of the jtf#38 gene. The jtf#38 cDNA was used to probe an ordered grid of yeast artificial chromosomes (YACs) following the protocol described by Coulson et al. (19) .
Sequencing of mutant alleles. RT-PCR was performed to amplify unc-63 and lev-1 from mutant alleles and the PCR products were sequenced. After a putative mutation was found in the cDNA, the corresponding genomic fragment from the mutants was amplified using single worm PCR Mutant rescue experiment. We were unable to make a GFP construct consisting of the entire unc-63 coding region for both rescue of unc-63 mutants and localization of the UNC-63 subunit.
Thus, for mutant rescue studies, we used a construct (punc-63.1) that was generated by PCR on wild type genomic DNA using the Expand Long Template System (Roche) and the primers TATTTGGCGGCCGCTCTGTGACTGCCTATGG and GGAAGAGGTACCATGGCAGAACACGTGATG (engineered restriction sites are underlined). Electrophysiology. Whole-cell, voltage clamp recordings were obtained from ventral, medial body wall muscles of dissected of C. elegans adults, as previously described (11) . An EPC-9 patch-clamp amplifier (HEKA, Lambrecht Germany) was deployed to record currents that were digitized at 2.9 kHz using an IT6 interface (Instrutech, Great Neck, New York). 4 NaATP; 36 sucrose; 5 EGTA (pH 7.2, ~315 mOsm). Subsequent analysis and graphing were carried out using Pulsefit (HEKA) and Igor Pro (Wavemetrics, Lake Oswego, Oregon).
Statistical analysis was performed using the unpaired t-test (for ACh responses) or the Mann
Whitney test (for levamisole responses and dihydro-β-erythroidine (DHβE) block). All statistically-derived values are given as mean ± S.E.M.
Chemicals. Unless otherwise indicated all chemicals were obtained from Sigma (UK).

Results
Cloning a novel C. elegans nAChR subunit
We employed a cross-hybridization strategy to identify new nAChRs in C. elegans. A C.
elegans cDNA phage library was screened at low stringency using the unc-38 and unc-29 cDNAs as probes. Several positive clones were obtained, including one which hybridized specifically at moderate stringency to the unc-38 cDNA probe. The clone was a partial cDNA whose amino acid sequence showed significant identity with previously characterized nAChR subunits. We utilized RACE PCR to complete the cDNA sequence and the RNA splice leader SL1 (22) was observed at the 5' end. The full-length cDNA clone was designated jtf#38
(GenBank accession number AAK83056).
Fig. 1 here Location of the jtf#38 clone on the C. elegans physical and genetic maps
We mapped the location of jtf#38 to YACs Y55F5 and Y72D6 on the physical map by hybridizing the cloned cDNA to a YAC grid (Fig. 1A) . Y55F5 and Y72D6 are located near the center of chromosome I. During the course of this study, the genomic sequence of the region containing jtf#38 was completed by the C. elegans sequencing consortium (23). We therefore compared the genomic region and jtf#38 cDNA sequences, and found that jtf#38 corresponds to the predicted gene Y110A7A.3 which encodes a putative nAChR subunit. The gene is composed of 10 exons spanning 7.5 kb (Fig. 1B) 
Y110A7A.3 is the unc-63 locus.
To test whether Y110A7A.3 corresponds to unc-63, we first sequenced Y110A7A.3 genomic DNA in five unc-63 mutant alleles. All mutant alleles were isolated using EMS mutagenesis (7). The unc-63 mutants exhibit a range of phenotypes from strongly uncoordinated locomotion with strong levamisole resistance (alleles x37, x13, x18) to almost wild type locomotion with mild levamisole resistance (alleles b404, x26). We found 1 missense mutation (x26), one nonsense mutation (x13), one deletion (b404) and 2 mutations (x37 and x18) that disrupt splice junction consensus sites (Fig. 1B) . These results provide strong evidence that unc-63 corresponds to the nAChR subunit encoded by Y110A7A.3. Together with the sequences of 5 unc-63 mutant alleles, these results show that the jtf#38 cDNA clone we isolated corresponds to the unc-63 gene. (Fig. 2) . A phylogenetic tree of C. elegans nAChR subunits based on derived sequence identity is shown in Figure 3 . As indicated in the tree, UNC-63 is most similar to UNC-38 sharing 49 % identity. However, it is interesting to note that in loop C of UNC-63 the typical YxCC motif is present rather than the unusual YxxCC motif found in loop C of UNC-38 (6). Fig. 3 here
The unc-63 gene is expressed in both muscle cells and neurons
To determine the tissue-specific localization of unc-63, we injected N2 animals with a genomic fragment of unc-63 fused to DNA encoding GFP (Green Fluorescent Protein (25)) as shown in Fig. 4A . In transgenic animals expressing the UNC-63::GFP fusion construct, fluorescence was observed in all body wall muscles and in vulval muscles (Fig. 4) . We also detected expression in many cells of the nervous system, including motor neurons in the ventral nerve cord (AS, DA, DB, VC, VA, VB and VD types) and neurons in head, posterior lateral, preanal and lumbar ganglia. The expression of unc-63 in both body wall muscles and motor neurons is consistent with locomotion defects observed for unc-63 mutants. 
LEV-1 is a possible partner for the UNC-63 α subunit in a native nAChR
The subunits, UNC-38, UNC-29 and LEV-1, are also associated with levamisole resistance in C.
elegans. Both UNC-29 (10) and UNC-38 (11) are expressed in the body wall muscles of C.
elegans, overlapping at least in part with the UNC-63 expression pattern. This raises the possibility that UNC-63, UNC-38 and UNC-29 subunits may co-assemble to form a native levamisole-sensitive receptor. To test whether LEV-1 might also be a component of this body wall muscle receptor, we determined the expression pattern of LEV-1. We made a gene fusion construct (LEV-1::GFP) with 4 kb of the lev-1 5' genomic sequence and the entire lev-1 genomic coding sequence fused at the C-terminus to GFP (Fig. 4A) . The transgene was then injected into the recessive lev-1 (e211) mutant. The lev-1(e211) allele contains a missense mutation (G461E) located in the M4 region and exhibits normal locomotion in the absence of levamisole, becoming uncoordinated (but not hypercontracted as with wild-type) in the presence of 1 mM levamisole.
Injected LEV-1::GFP restored levamisole sensitivity to the lev-1 mutant, demonstrating that the transgene rescued lev-1(e211) and, as shown in Fig. 4 (I-J) , GFP expression was observed in all body wall muscle cells and in a subset of motor neurons in the ventral nerve cord. Thus LEV-1 has overlapping expression with UNC-63 as well as UNC-38 and UNC-29. and decay, and the same cells responded to 100 µM levamisole with similar currents but with slower onset and decay. As shown in Fig. 5A , the response to 100 µM levamisole was almost completely abolished for unc-63(x37) and dramatically reduced to only 14% of that observed in the wild type in lev-1(e211) . We then tested whether the second nAChR type was still present in both mutants by pressure-application of ACh onto voltage-clamped body wall muscle cells of unc-63(x37) and lev-1(e211) mutants (Fig. 5B) . In both mutants, ACh elicited a robust inward current although the responses were smaller than the wild type. This reduction in response to ACh is consistent with loss of levamisole receptor contribution to the total ACh response in unc-63(x37) and lev-1(e211). We also measured the effects of DHβE on the ACh-elicited responses (Fig. 5B) . In wild type worms the inward current was blocked by 84%, whereas in lev- 1(e211) there was an 89% block and an almost complete block of 95% was observed in unc-63(x37), consistent with loss of the second muscle nAChR type.
Overall, these data suggest that levamisole-sensitive receptors in body wall muscle require the functional expression of UNC-63 and LEV-1 in addition to UNC-29 and UNC-38.
DISCUSSION
Levamisole is a potent anthelmintic drug, which is used to eradicate nematode infestations in a number of domestic animals (26) . Application of levamisole to wild-type C.
elegans causes muscle hypercontraction, paralysis and ultimately death, although the exact cause of death is unknown. Through the analysis of levamisole-resistant mutants we can begin to understand the actions of levamisole by identifying targets within the worm that are required for levamisole sensitivity. Previous studies suggest that the molecular targets of levamisole include nAChRs at the C. elegans neuromuscular junction (8, 9, 11) . Application of levamisole directly onto voltage-clamped C. elegans body wall muscles produces inward currents that are abolished in mutants encoding the nAChR subunits UNC-38 and UNC-29 (11) . This observation is consistent with the muscle expression of these two subunits and can explain the observed muscle hypercontraction of worms exposed to levamisole.
Here we report the identification of a novel nAChR subunit in C. elegans which shows greatest sequence similarity with UNC-38 and physically maps in the vicinity of unc-63, one of 11 loci identified in genetic screens for mutants that confer levamisole resistance (7) . Sequence We have also demonstrated that LEV-1, in addition to UNC-63, UNC-38 and UNC-29, is expressed in body wall muscles of C. elegans. The lev-1(e211) mutant worms are resistant to levamisole although their locomotion appears normal. Electrophysiological analysis of the lev-1(e211) mutant animals indicated that 86% of the levamisole-sensitive current was abolished (Fig. 5A) . Since the lev-1(e211) produces a missense mutation, the residual levamisole response may reflect only a partial loss-of-function of the LEV-1 subunit or the presence of a poison subunit that reduces the efficacy of the heteromeric receptor. Alternatively, the LEV-1 subunit may be less essential, possibly being replaced by other non-α subunits such as UNC-29.
We also show that UNC-63 and LEV-1 subunits, like UNC-29 and UNC-38, are LEV-1 are most similar to the non-α subunits ACR-2 and ACR-3 (Fig. 3) . Whereas ACR-6 has yet to be characterized, ACR-2 or ACR-3 coexpress with UNC-38 in Xenopus oocytes to form functional ion channels upon which levamisole acts as an agonist (29, 30) . Indeed, ACR-2 was shown to be expressed in a number of ventral cholinergic motor neurons (28) 
